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Abstracts / International Journal of Surgery 9 (2011) 363–369366UNOPERATED patients with unoperated infra-renal aortic aneurysms.
Adjustments between groups were made for age, sex, mean arterial
pressure, creatinine and the presence of diabetes using linear regression
analysis. PWV was represented as the mean [95% CI lower-upper].
Results: A total of 105 studies were performed, CONTROL n¼27,
THORACIC n¼30, ABDOMINAL n¼25, UNOPERATED n¼23. The ABDOM-
INAL group had an adjusted PWV of 11.9m/s [10.8-13.1], signiﬁcantly
higher than CONTROLS 8.8m/s [8.5-9.2] (p<0.001), THORACIC 8.8m/s [8.0-
9.6] (p<0.001), and UNOPERATED 8.9m/s [8.0-9.8] (p<0.001).
Conclusions: These data suggests that the replaced abdominal aorta
reduces arterial compliance. Thoracic grafting does not have an effect on
PWV indicating that the proximal aorta contributes less to tonometric
measurements of arterial stiffness. We provide a basis for future work to
investigate how prosthetic aortic replacement affects ventricular-arterial
coupling and the impact of pharmacological manipulation of vascular
function in such patients.PROGNOSTIC SIGNIFICANCE OF TOTAL DISEASE LENGTH IN
OESOPHAGEAL CANCER
J.D. Mason, L.l. Davies, T.D. Reid, M. Robinson, T.D. Crosby, S.A. Roberts,
W.G. Lewis. South East Wales Upper GI Cancer Network
Background: Oesophageal tumour length has long been considered an
important prognostic indicator in oesophageal cancer (OC), and typically
an operable tumour has been considered to be T1-3, N0-1, M0, with an
endoscopic deﬁned length of 5 cm or less.
Aims: The aim of this study was to test the hypothesis that endoluminal
ultrasound (EUS) deﬁned total length of disease (including both the
primary tumour and the position and number of proximal and distal
lymph nodes - ELoD) and the associated EUS lymph node metastasis count
(ELNMC) are better predictors of outcome than endoscopic OC length and
radiological TNM stage in patients undergoing potentially curative therapy
with either surgery or deﬁnitive chemoradiotherapy (dCRT).
Methods: 610 consecutive patients diagnosed with OC and managed by
a multidisciplinary teamwere staged by CT and EUS. The primary outcome
measure was survival from date of diagnosis.
Results: 302 patients received surgery and 308 patients received dCRT.
Univariable analysis revealed that survival was related to EUS T (p<0.001),
N (p<0.001), M1a (p¼0.041) stage, ELoD (p¼0.009), ELNMC (p<0.001),
and treatment type (p¼0.003). Multivariable analysis revealed two factors;
ELoD (HR 0.960 95% CI 0.923-0.999, p¼0.047) and ELNMC (HR 1.123, 95% CI
1.062-1.188, p<0.001) were independently associated with survival.
Conclusion: ELoD and ELNMC should become part of routine OC radio-
logical staging reports to optimise stage directed therapeutic outcomes.ROLE OF POSITRON EMISSION TOMOGRAPHY (PET) IN PANCREATIC
RESECTION FOR SUSPECTED PANCREATIC AND PERIAMPULLARY
CANCER
V. Allen, K.S. Gurusamy, A. Kalia, B.R. Davidson. Department of Surgery,
Royal Free Campus - UCL Medical School, 9th Floor Royal Free Hospital,
Pond Street, London. NW3 2QG
Background: A signiﬁcant proportion of patients undergo unnecessary
laparotomy because of incorrect diagnosis and understaging of pancreatic
and periampullary cancer.
Methods: A systematic review of studies assessing PET was performed.
Medline, Embase, Cochrane trials register, and Science Citation Index were
searched until November 2009. The gold standard test was laparotomy
with histological conﬁrmation. Meta-analysis was performed using
bivariate method and Littenberg-Moses method.
Results: Seven studies including 336 patients were included in the meta-
analysis for distinguishing benign from malignant disease. The summary
sensitivity and speciﬁcity were 0.892 and 0.745. This corresponds to a post-
test probability of 0.91 for a positive PET and 0.30 for a negative PET.
compared to a baseline probability of 0.75. Two studies including a total of
199 patients (who had undergone CT scan as standard work-up) were
included in the meta-analysis for assessing resectability with curativeintent. The summary sensitivity and speciﬁcity were 0.92 and 0.87. This
corresponds to a post-test probability of 0.56 for a positive PET (i.e. patient
has a 44% probability of curative resection if PET was positive) and 0.02 for
a negative PET (i.e. patient has a 98% probability of curative resection if PET
was negative) compared to a baseline probability of 0.15 (i.e. patient has
a 85%probability of curative resection if laparotomywas donewithout PET).
Conclusions: PET has no role in distinguishing benign and malignant
periampullary disease. A positive PET scan is unreliable but a negative PET
scan can conﬁrm curative resectability with high accuracy.AN ANALYSIS OF TUMOURIGENESIS IN HUMAN MESENCHYMAL STEM
CELLS EXPANDED IN VITRO
Clare Byrne. University of Aberdeen School of Medicine
5-10% of fractures demonstrate signiﬁcantly delayed healing or non-union.
Although skeletal ﬁxation has achieved limited success, no ideal treatment
for non-union exists1. One potential is the use of human mesenchymal
stem cells (hMSC's) to enhance fracture healing. While hMSC's display
immunosuppressive properties reducing the likelihood of rejection, side-
effects could include tumourigenesis2.
Objectives: 1. Do hMSC's become tumourigenic when expanded in
vitro and grown on agar?
2. Do time, cell concentration and passage number affect
tumourigenesis?
Materials & Methods: hMSC's were obtained from bone marrow aspi-
rates from iliac crests of patients undergoing surgical treatment for non-
union tibial fractures. Cells from 4 patients at 3 passages, positive (HCT
cells) and negative control lines (AA/CI cells), were seeded onto agar plates
at different concentrations. Plates were incubated at 37oC, 5% CO2 for 4
weeks. Tumour colony numbers (image 1) and tumourigenicity were
calculated weekly.
Image 1: Tumour colonyScale Bar: 20m ¼ 2cm
Results: 1. hMSC lines produced no colonies (p<0.001)
2. Higher cell concentrations result in increased colony numbers
(p<0.001)
3. Colony numbers decreased with time (p<0.001)
Conclusions: Tumourigenesis did not occur in hMSC's expanded in vitro.
These results may support existing studies conﬁrming hMSC's can be
safely expanded in vitro for therapeutic use.
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